Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

378 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Automated Contouring and Planning in Radiation Therapy: What Is 'Clinically Acceptable'?
Baroudi H, Brock KK, Cao W, Chen X, Chung C, Court LE, El Basha MD, Farhat M, Gay S, Gronberg MP, Gupta AC, Hernandez S, Huang K, Jaffray DA, Lim R, Marquez B, Nealon K, Netherton TJ, Nguyen CM, Reber B, Rhee DJ, Salazar RM, Shanker MD, Sjogreen C, Woodland M, Yang J, Yu C, Zhao Y. Baroudi H, et al. Among authors: farhat m. Diagnostics (Basel). 2023 Feb 10;13(4):667. doi: 10.3390/diagnostics13040667. Diagnostics (Basel). 2023. PMID: 36832155 Free PMC article. Review.
Phase II trial of proton therapy versus photon IMRT for GBM: secondary analysis comparison of progression-free survival between RANO versus clinical assessment.
Al Feghali KA, Randall JW, Liu DD, Wefel JS, Brown PD, Grosshans DR, McAvoy SA, Farhat MA, Li J, McGovern SL, McAleer MF, Ghia AJ, Paulino AC, Sulman EP, Penas-Prado M, Wang J, de Groot J, Heimberger AB, Armstrong TS, Gilbert MR, Mahajan A, Guha-Thakurta N, Chung C. Al Feghali KA, et al. Among authors: farhat ma. Neurooncol Adv. 2021 Jun 1;3(1):vdab073. doi: 10.1093/noajnl/vdab073. eCollection 2021 Jan-Dec. Neurooncol Adv. 2021. PMID: 34337411 Free PMC article.
Paradoxical Association Between Relative Cerebral Blood Volume Dynamics Following Chemoradiation and Increased Progression-Free Survival in Newly Diagnosed IDH Wild-Type MGMT Promoter Methylated Glioblastoma With Measurable Disease.
Goldman J, Hagiwara A, Yao J, Raymond C, Ong C, Bakhti R, Kwon E, Farhat M, Torres C, Erickson LG, Curl BJ, Lee M, Pope WB, Salamon N, Nghiemphu PL, Ji M, Eldred BS, Liau LM, Lai A, Cloughesy TF, Chung C, Ellingson BM. Goldman J, et al. Among authors: farhat m. Front Oncol. 2022 Mar 8;12:849993. doi: 10.3389/fonc.2022.849993. eCollection 2022. Front Oncol. 2022. PMID: 35371980 Free PMC article.
Additive Value of MR Simulation Prior to Chemoradiation in Evaluating Treatment Response and Pseudoprogression in High-Grade Gliomas.
Yadav D, Upadhyay R, Kumar VA, Chen MM, Johnson JM, Langshaw H, Curl BJ, Farhat M, Talpur W, Beckham TH, Yeboa DN, Swanson TA, Ghia AJ, Li J, Chung C. Yadav D, et al. Among authors: farhat m. Pract Radiat Oncol. 2024 Apr 27:S1879-8500(24)00089-4. doi: 10.1016/j.prro.2024.04.009. Online ahead of print. Pract Radiat Oncol. 2024. PMID: 38685448
Precision Phenotyping for Curating Research Cohorts of Patients with Post-Acute Sequelae of COVID-19 (PASC) as a Diagnosis of Exclusion.
Azhir A, Hügel J, Tian J, Cheng J, Bassett IV, Bell DS, Bernstam EV, Farhat MR, Henderson DW, Lau ES, Morris M, Semenov YR, Triant VA, Visweswaran S, Strasser ZH, Klann JG, Murphy SN, Estiri H. Azhir A, et al. Among authors: farhat mr. medRxiv [Preprint]. 2024 Apr 16:2024.04.13.24305771. doi: 10.1101/2024.04.13.24305771. medRxiv. 2024. PMID: 38699316 Free PMC article. Preprint.
Unlocking Hope: Anti-VEGFR inhibitors and their potential in glioblastoma treatment.
Berro A, Assi A, Farhat M, Hatoum L, Saad JP, Mohanna R, Bechara AMA, Prince G, Hachem MCR, Zalaquett Z, Kourie HR. Berro A, et al. Among authors: farhat m. Crit Rev Oncol Hematol. 2024 Apr 25;198:104365. doi: 10.1016/j.critrevonc.2024.104365. Online ahead of print. Crit Rev Oncol Hematol. 2024. PMID: 38677355 Review.
378 results